|

Optical Genome Mapping in Hematological Malignancies

RECRUITINGSponsored by University Hospital, Brest
Actively Recruiting
SponsorUniversity Hospital, Brest
Started2021-09
Est. completion2022-09
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05009537

Summary

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Minor/Major Patients
* Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
* No objection made or consent given

Exclusion Criteria:

* Patients under judicial protection (guardianship, curatorship, ...),
* Refusal to participate

Conditions4

AllCancerMDSOther Hematologic Malignant Neoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.